Search

Dale R. Miller

Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1673, 1693
Total Applications
838
Issued Applications
502
Pending Applications
84
Abandoned Applications
276

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16761028 [patent_doc_number] => 20210106609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => HEALTH SUPPLEMENT [patent_app_type] => utility [patent_app_number] => 17/070810 [patent_app_country] => US [patent_app_date] => 2020-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/070810
Health supplement Oct 13, 2020 Issued
Array ( [id] => 16596524 [patent_doc_number] => 20210023055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => MOFEZOLAC DERIVATIVES AS MULTI-FUNCTIONS SELECTIVE COX-1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/062269 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062269 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/062269
Mofezolac derivatives as multi-functions selective COX-1 inhibitors Oct 1, 2020 Issued
Array ( [id] => 16671293 [patent_doc_number] => 20210060056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION [patent_app_type] => utility [patent_app_number] => 17/060343 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3467 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060343 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060343
Ophthalmic compositions with improved dessication protection and retention Sep 30, 2020 Issued
Array ( [id] => 18056377 [patent_doc_number] => 20220387463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => TREHALOSE FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/765059 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765059
Trehalose formulations and uses thereof Sep 28, 2020 Issued
Array ( [id] => 18280229 [patent_doc_number] => 20230095701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => Use of Albiflorin in Treatment of Coronavirus Pneumonia [patent_app_type] => utility [patent_app_number] => 17/802806 [patent_app_country] => US [patent_app_date] => 2020-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/802806
Use of Albiflorin in Treatment of Coronavirus Pneumonia Sep 24, 2020 Abandoned
Array ( [id] => 16686760 [patent_doc_number] => 20210069235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => COMPOSITION FOR TREATING JOINT DISEASE AND KIT CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 17/026910 [patent_app_country] => US [patent_app_date] => 2020-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/026910
Composition for treating joint disease and kit containing same Sep 20, 2020 Issued
Array ( [id] => 16555820 [patent_doc_number] => 20210000968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND [patent_app_type] => utility [patent_app_number] => 17/024368 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28185 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024368 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/024368
ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND Sep 16, 2020 Abandoned
Array ( [id] => 16621584 [patent_doc_number] => 20210040237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => NANO-CRYSTALLINE CELLULOSE [patent_app_type] => utility [patent_app_number] => 17/021066 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/021066
Nano-crystalline cellulose Sep 14, 2020 Issued
Array ( [id] => 16539436 [patent_doc_number] => 20200405849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => VACCINE SYSTEM FOR VACCINE ADJUVANT [patent_app_type] => utility [patent_app_number] => 17/018975 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018975 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/018975
VACCINE SYSTEM FOR VACCINE ADJUVANT Sep 10, 2020 Pending
Array ( [id] => 17944465 [patent_doc_number] => 20220331482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => Hydrogel Composition For Tissue Regeneration, And Support Prepared Using Same [patent_app_type] => utility [patent_app_number] => 17/763136 [patent_app_country] => US [patent_app_date] => 2020-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763136 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763136
Hydrogel Composition For Tissue Regeneration, And Support Prepared Using Same Aug 31, 2020 Abandoned
Array ( [id] => 16523864 [patent_doc_number] => 20200397944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS [patent_app_type] => utility [patent_app_number] => 17/007533 [patent_app_country] => US [patent_app_date] => 2020-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9013 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/007533
HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS Aug 30, 2020 Abandoned
Array ( [id] => 16555700 [patent_doc_number] => 20210000848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION [patent_app_type] => utility [patent_app_number] => 17/001118 [patent_app_country] => US [patent_app_date] => 2020-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9787 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001118 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/001118
Synthetic composition for microbiota modulation Aug 23, 2020 Issued
Array ( [id] => 16657378 [patent_doc_number] => 20210054014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => POLYMORPHIC FORMS OF DEOXYCYTIDINE, COMPOSITIONS COMPRISING THE SAME AND USES [patent_app_type] => utility [patent_app_number] => 16/997727 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10979 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997727 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/997727
Polymorphic forms of deoxycytidine, compositions comprising the same and uses Aug 18, 2020 Issued
Array ( [id] => 17805021 [patent_doc_number] => 20220256856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => Antifungal composition comprising natamycin and at least one insecticide [patent_app_type] => utility [patent_app_number] => 17/630313 [patent_app_country] => US [patent_app_date] => 2020-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630313 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/630313
Antifungal composition comprising natamycin and at least one insecticide Aug 12, 2020 Issued
Array ( [id] => 16712023 [patent_doc_number] => 20210079170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => PREPARATION METHOD OF 4D CHITOSAN-BASED THERMOSENSITIVE HYDROGEL [patent_app_type] => utility [patent_app_number] => 16/984626 [patent_app_country] => US [patent_app_date] => 2020-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2808 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984626 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/984626
Preparation method of 4D chitosan-based thermosensitive hydrogel Aug 3, 2020 Issued
Array ( [id] => 18091308 [patent_doc_number] => 20220409649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => a-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR ABSORPTION INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/633869 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633869 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/633869
a-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR ABSORPTION INHIBITOR Aug 2, 2020 Abandoned
Array ( [id] => 16930734 [patent_doc_number] => 20210196623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => NOVEL PARENTERAL CARBAMAZEPINE FORMULATION [patent_app_type] => utility [patent_app_number] => 16/939390 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939390 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/939390
NOVEL PARENTERAL CARBAMAZEPINE FORMULATION Jul 26, 2020 Abandoned
Array ( [id] => 17805791 [patent_doc_number] => 20220257626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => TREATMENT COMPRISING SGLT INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/628857 [patent_app_country] => US [patent_app_date] => 2020-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6436 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628857 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/628857
TREATMENT COMPRISING SGLT INHIBITORS Jul 20, 2020 Abandoned
Array ( [id] => 16397245 [patent_doc_number] => 20200338103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION [patent_app_type] => utility [patent_app_number] => 16/927629 [patent_app_country] => US [patent_app_date] => 2020-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927629 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/927629
HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION Jul 12, 2020 Abandoned
Array ( [id] => 17089751 [patent_doc_number] => 11117928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Glycoconjugation process [patent_app_type] => utility [patent_app_number] => 16/923154 [patent_app_country] => US [patent_app_date] => 2020-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17759 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923154 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/923154
Glycoconjugation process Jul 7, 2020 Issued
Menu